Literature DB >> 12428902

Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol).

C Allen1, N Dos Santos, R Gallagher, G N C Chiu, Y Shu, W M Li, S A Johnstone, A S Janoff, L D Mayer, M S Webb, M B Bally.   

Abstract

The presence of poly(ethylene glycol) (PEG) at the surface of a liposomal carrier has been clearly shown to extend the circulation lifetime of the vehicle. To this point, the extended circulation lifetime that the polymer affords has been attributed to the reduction or prevention of protein adsorption. However, there is little evidence that the presence of PEG at the surface of a vehicle actually reduces total serum protein binding. In this review we examine all aspects of PEG in order to gain a better understanding of how the polymer fulfills its biological role. The physical and chemical properties of the polymer are explored and compared to properties of other hydrophilic polymers. An evidence based assessment of several in vitro protein binding studies as well as in vivo pharmacokinetics studies involving PEG is included. The ability of PEG to prevent the self-aggregation of liposomes is considered as a possible means by which it extends circulation longevity. Also, a "dysopsonization" phenomenon where PEG actually promotes binding of certain proteins that then mask the vehicle is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428902     DOI: 10.1023/a:1020186505848

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  68 in total

1.  Selective non-covalent triggered release from liposomes.

Authors:  Adam J Plaunt; Meghan B Courbanou; Katrina D Cuison; Kara M Harmatys; Bradley D Smith
Journal:  Chem Commun (Camb)       Date:  2012-07-09       Impact factor: 6.222

Review 2.  Effect of surface properties on liposomal siRNA delivery.

Authors:  Yuqiong Xia; Jie Tian; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

3.  Supramolecular Polymer Hydrogels for Drug-Induced Tissue Regeneration.

Authors:  Jing Cheng; Devang Amin; Jessica Latona; Ellen Heber-Katz; Phillip B Messersmith
Journal:  ACS Nano       Date:  2019-05-14       Impact factor: 15.881

4.  Vesicle size and stability of biomimetic liposomes from 3'-sulfo-Lewis a (SuLea) containing glycolipids.

Authors:  Junmin Zhu; Jie Xue; Zhongwu Guo; Roger E Marchant
Journal:  Colloids Surf B Biointerfaces       Date:  2007-03-27       Impact factor: 5.268

5.  Intracellular delivery of VIP-grafted sterically stabilized phospholipid mixed nanomicelles in human breast cancer cells.

Authors:  Israel Rubinstein; Imre Soos; Hayat Onyuksel
Journal:  Chem Biol Interact       Date:  2007-04-06       Impact factor: 5.192

6.  Plasma clearance of bacteriophage Qbeta particles as a function of surface charge.

Authors:  Duane E Prasuhn; Pratik Singh; Erica Strable; Steven Brown; Marianne Manchester; M G Finn
Journal:  J Am Chem Soc       Date:  2008-01-05       Impact factor: 15.419

Review 7.  Recent developments in cyclic acetal biomaterials for tissue engineering applications.

Authors:  Erin E Falco; Minal Patel; John P Fisher
Journal:  Pharm Res       Date:  2008-06-07       Impact factor: 4.200

8.  Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.

Authors:  Yang Liu; Yunxia Hu; Leaf Huang
Journal:  Biomaterials       Date:  2014-01-02       Impact factor: 12.479

9.  The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma.

Authors:  Santosh S Dhule; Patrice Penfornis; Jibao He; Michael R Harris; Treniece Terry; Vijay John; Radhika Pochampally
Journal:  Mol Pharm       Date:  2014-01-24       Impact factor: 4.939

10.  Targeting microspheres and cells to polyethylene glycol-modified biological surfaces.

Authors:  Timothy E Deglau; Jermaine D Johnson; Flordeliza S Villanueva; William R Wagner
Journal:  J Biomed Mater Res A       Date:  2007-06-01       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.